Skip to main content
. 2017 Sep 27;6(11):2507–2514. doi: 10.1002/cam4.1205

Table 3.

Distribution of uptake according to BMB and PET/CT

PET/CT Global series (N = 268) R‐CHOP/21 coHORTa (n = 203)
BMB
Negative Positive Total Negative Positive Total
Negative 197 11 208 151 10 161
Positive 36 24 60 26 16 42
Total 233 35 268 177 26 203

BMB, bone marrow biopsy; PET/CT, possitron emission tomography/computer tomography.

a

Patients treated with R‐CHOP/21 as first‐line therapeutic strategy.